ATEC ATEC Spine Market Value to Book Value Ratio

ATEC Spine - graphic logo of issuer ATEC

The price action visualization for Alphatec Holdings, Inc. (ATEC) on the GURU.Markets platform demonstrates the market position of the company, whose indicator stands at -141.43. The business is strengthening its competitive advantages through SafeOp, creating switching barriers for neurosurgeons moving to other systems. Growth is driven by the implementation of PTP, which guarantees stable demand for high-cost titanium products, while automated milling capacities minimize production errors with physician support.

Alphatec Corp (ATEC) Market Capitalization to Net Assets: for the period 07/04/2022 - 10/29/2026
Flagship merchandise of Alphatec Holdings

This ratio compares the current market value of Alphatec Holdings, Inc. (ATEC) to its net assets, determining the market premium for growth potential or the risk of capital degradation. By analyzing the market capitalization-to-book ratio, an investor assesses resource efficiency, which for Alphatec Holdings, Inc. (ATEC) is supported by the high value of proprietary systems and software that create a defensive barrier against competitors.

Competitor analysis

BSX: Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio edwards.com|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|CryoLife (AORT) - Market Cap to Net Assets Ratio|ENOV: Market Capitalization to Book Value Ratio|IART - Market Capitalization to Book Value|ESTA (Establishment Labs) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio betabionics.com|Market Value to Book Value Ratio IRADIMED (IRMD)|Market Value to Book Value Ratio EMBC (Embecta Corp)|Market Capitalization to Book Value Ratio TNDM (Tandem Diabetes)|Market Capitalization to Book Value Axogen Surgical (AXGN)|SIBN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets OFIX|BVS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio OrthoPediatrics (KIDS)|TMCI (Treace Medical) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio SRTA (Strata Medical)|Market Cap to Net Assets Ratio CARL (Carlsmed Inc)|RXST (rxsight.com) - Market Value to Book Value|Market Value to Book Value Ratio ClearPoint Neuro CLPT|STXS - Market Cap to Net Assets Ratio|NeuroStar - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Sight Sciences Inc|OBIO: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ANIK|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.